2BBBullish & Bearish
ProMIS Neurosciences Inc. (PMN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 27 out of 100.
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases.
ProMIS Neurosciences Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 14 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 27 | Weak |
| Quality | 40 | Normal |
| Risk | 54 | Moderate (provisional) |
| Headquarters | Mississauga, Ontario, Canada |
| Founded | 2005 |
| Employees | 11 |
| 52-week range | $2.78 – $27.40 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-23 | — | -1.3113 | — | $0.00 |
| 2026-11-12 | — | -1.2911 | — | $0.00 |